🔗 Share this article

A shadow market for unlicensed slimming drugs is propelled by TikTok fitness influencers and sellers on messaging platforms, based on recent findings.

Experimental Drug Acquiring Traction Via Social Media

The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its alleged fat-burning effects. Viewers are encouraged to contact these accounts privately for source information, while also obtaining discount codes.

Active Trade on Social Networks

Separately, a robust market exists on Telegram, where communities with thousands of members share “before and after” images, injection guides and assertions of next-day UK delivery. Vendors promote the drug there before redirecting customers to WhatsApp for transactions.

Learning About Retatrutide

Retatrutide is an experimental injectable developed by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could help patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the substance is being promoted digitally as the successor to Ozempic.

Medical Professionals Voice Worries

However, physicians and pharmacists have cautions that the sale of what is still an unlicensed drug in the UK is worrisome and could lead to users injecting products of uncertain source.

Several experts said the popularity for the experimental drug could be connected to the increasing cost of approved weight loss products such as Mounjaro.

Legal Status and Implementation

Marketing the unapproved drug on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unlicensed drug that must not be promoted or supplied for human use under the British medical regulations.

Some content creators attempt to circumvent the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and supply can still breach pharmaceutical, marketing, and customer regulations, risking fines, prosecution or imprisonment.

Service Reaction and Material Removal

According to the social media company, the platform has removed problematic content and prohibited related keywords and query recommendations. The company stated it was dedicated to maintaining the service safe and investing in strengthening enforcement strategies.

Digital Trading Activities

Investigations also found communities with up to nine thousand members selling retatrutide using Telegram's integrated discovery tool, which operates like a public directory. Typing “retatrutide” immediately displays channels with thousands of members, populated with images of weight loss, glowing testimonials and detailed guides for mixing or administering at residence.

After minutes of joining one group, a vendor posted contact information, where most purchases take place. The seller sent an guidebook and promised delivery within 48 hours. When questioned whether the product was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. None asked about weight, medical conditions or past usage.

Item Information and Pricing

Inside these groups, messages display dark colored packages with postal service labels, stating to include new batches. One message stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at residence with purified liquid, or ready-to-use pens usually priced at 160 pounds for 20mg. When questioned how much time a pen should be used, vendors give conflicting responses varying between a several days to “depends on your body”.

Platform Moderation and Safety Actions

A representative for the messaging service said it actively moderated dangerous material on its service including content that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Medical Expert Warnings

“Individuals are administering substances they can’t verify. Although the science behind retatrutide is valid, these online versions may not include what they claim,” stated Jason Murphy, the head of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor connected the surge in demand to recent cost increases for approved slimming drugs such as Mounjaro. “With costs rising, individuals are turning to social media. But counterfeit treatments are highly risky. You can’t be certain what’s inside or whether the conditions they were produced in was clean,” she said.

Her staff has previously encountered patients harmed by personal administration from unverified sources. “We recognize the disappointment, but purchasing from messaging apps or WhatsApp is taking chances with your well-being,” stated Wyllie. “These materials could be contaminated or improperly measured.”

Manufacturer Position

A representative from Eli Lilly stated retatrutide was in third stage clinical trials and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Consequently at this time no one can market [it] for human use,” they said, adding that any product “falsely representing itself as a Lilly investigational product not yet authorized … may expose users to potentially significant medical dangers”.